Medicare Enrolled
Dr. Gregory Hester, MD
Urology Physician · Houston, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hester from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hester?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hester
Dr. Gregory Hester is an urology physician in Houston, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Hester performed 4,253 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Hester received a total of $6,706 from 51 pharmaceutical and/or device companies across 198 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hester is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 28% volume in TX
$6,706 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗4,253
Medicare services
Top 28% in TX for urology physician
Not available
Unique patients (not deduplicated)
$38
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
724 | $8 | $11 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
700 | $2 | $2 |
| Leuprolide injectable, camcevi, 1 mg | 630 | $59 | $75 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
585 | $88 | $136 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
507 | $10 | $15 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
358 | $8 | $8 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
260 | $62 | $95 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
108 | $108 | $181 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
92 | $50 | $64 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 72 | $139 | $187 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
67 | $60 | $258 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
29 | $24 | $35 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
25 | $77 | $116 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
22 | $104 | $250 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
22 | $26 | $33 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
17 | $25 | $31 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
12 | $60 | $77 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
12 | $11 | $15 |
| Laser vaporization of prostate A procedure that uses a laser to remove excess prostate tissue through an endoscope. The process includes controlling any bleeding that occurs during the treatment. |
11 | $527 | $1,681 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$6,706
Total received (2018-2024)
Avg $958/year across 7 years
Top 29% in TX for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
198
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,895
2023
$1,554
2022
$704
2021
$446
2020
$1,096
2019
$485
2018
$526
Payments by company (2024)
Astellas Pharma US Inc
$276
Boston Scientific Corporation
$249
Medtronic, Inc.
$198
PROCEPT BioRobotics Corporation
$187
Ferring Pharmaceuticals Inc.
$174
Sumitomo Pharma America, Inc.
$124
IMMUNITYBIO, INC.
$64
PROGENICS PHARMACEUTICALS, INC.
$62
Laborie Medical Technologies Corp.
$57
Merck Sharp & Dohme LLC
$54
Novo Nordisk Inc
$54
UROGEN PHARMA, INC.
$49
HealthTronics Stone Solutions, LLC
$49
Olympus America Inc.
$42
Verity Pharmaceuticals Inc.
$42
Myriad Genetic Laboratories, Inc.
$35
Dendreon Pharmaceuticals LLC
$34
180 Medical, Inc.
$28
C. R. Bard, Inc. & Subsidiaries
$25
PFIZER INC.
$23
Tempus AI, Inc
$23
ACCORD HEALTHCARE, INC.
$21
ABBVIE INC.
$18
Ambu Inc.
$7
Top 3 companies account for 38.2% of 2024 payments
All-time payments by company (2018-2024) ›
NeoTract Inc.
$936
Astellas Pharma US Inc
$896
Boston Scientific Corporation
$667
Endo Pharmaceuticals Inc.
$418
PFIZER INC.
$311
Ferring Pharmaceuticals Inc.
$284
PROCEPT BioRobotics Corporation
$241
Medtronic, Inc.
$236
BOSTON SCIENTIFIC CORPORATION
$190
Sumitomo Pharma America, Inc.
$189
C. R. Bard, Inc. & Subsidiaries
$173
180 Medical, Inc.
$126
Myriad Genetic Laboratories, Inc.
$126
AstraZeneca Pharmaceuticals LP
$124
Merck Sharp & Dohme LLC
$123
ABBVIE INC.
$88
TOLMAR Pharmaceuticals, Inc.
$87
ConvaTec Inc.
$86
Ambu Inc.
$75
AbbVie Inc.
$67
Alnylam Pharmaceuticals Inc.
$65
IMMUNITYBIO, INC.
$64
Amgen Inc.
$62
PROGENICS PHARMACEUTICALS, INC.
$62
Supernus Pharmaceuticals, Inc.
$58
Progenics Pharmaceuticals, Inc.
$58
Laborie Medical Technologies Corp.
$57
Novo Nordisk Inc
$54
UroGen Pharma, Inc.
$53
UROGEN PHARMA, INC.
$49
HealthTronics Stone Solutions, LLC
$49
Antares Pharma, Inc.
$48
Olympus America Inc.
$42
Medtronic USA, Inc.
$42
Verity Pharmaceuticals Inc.
$42
Janssen Biotech, Inc.
$42
ACCORD HEALTHCARE, INC.
$41
Avadel Specialty Pharmaceuticals, LLC
$41
Teleflex LLC
$36
AbbVie, Inc.
$35
Axonics, Inc.
$35
Dendreon Pharmaceuticals LLC
$34
UROVANT SCIENCES INC
$26
Tolmar, Inc.
$25
Tempus AI, Inc
$23
ABC Home Medical Supply, Inc.
$23
Merck Sharp & Dohme Corporation
$22
BioTissue Holdings, Inc.
$21
Bayer HealthCare Pharmaceuticals Inc.
$19
Coloplast Corp
$19
Telix Pharmaceuticals
$17
Top 3 companies account for 37.3% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Axonics · Bard Urinary Drainage Bag · CAMCEVI · CURE CATHETER · CURE ULTRA CATHETER · Dornier MedTech · ELIGARD · ERLEADA · GEMTESA · GENERAL BPH · GENERAL FEMALE SUI · GENERAL FEMALE SUI · GENTLECATH · GIVLAARI · GREENLIGHT · General - BPH · ILLUCCIX · INTERSTIM · JELMYTO · KEYTRUDA · LUPRON DEPOT · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NEOX · NOCDURNA · Noctiva · Nubeqa · ORGOVYX · OTREXUP · OXLUMO · Optilume BPH Drug Coated Balloon Catheter · PREMARIN · PROLARIS · PROVENGE · PYLARIFY · Prolia · Rezum Generator · Rivfloza · Solyx SIS System · SpaceOAR VUE System - 10mL · SpeediCath · TLANDO · TOVIAZ · Tlando · Trelstar · UROLIFT · UroLift · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xtandi · iTIND System · rezum Generator
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
199
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
MEMORIAL HERMANN MEMORIAL CITY HOSPITAL
2.2 mi
2.2 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hester is a clinical cardiology specialist, with above-average Medicare volume (top 28% in TX), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hester experienced with bladder ultrasound after voiding?
Based on Medicare claims data, Dr. Hester performed 724 bladder ultrasound after voiding services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Hester receive payments from pharmaceutical companies?
Yes. Dr. Hester received a total of $6,706 from 51 companies across 198 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hester's costs compare to other urology physicians in Houston?
Dr. Hester's average Medicare payment per service is $38. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hester) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Houston
Browse urology physicians in Houston ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology